BIOMAT Database Logo BIOMAT Database Logo

The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems. 1990

A Mansour, and J H Meador-Woodruff, and D M Camp, and T E Robinson, and J Bunzow, and H Van Tol, and O Civelli, and H Akil, and S J Watson
MHRI, U Mich, Ann Arbor 48109.

UI MeSH Term Description Entries
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004745 Enkephalins One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla. Enkephalin
D006892 Hydroxydopamines Dopamines with a hydroxy group substituted in one or more positions. Hydroxydopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D016627 Oxidopamine A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals. 6-Hydroxydopamine,6-OHDA,Oxidopamine Hydrobromide,Oxidopamine Hydrochloride,6 Hydroxydopamine,Hydrobromide, Oxidopamine,Hydrochloride, Oxidopamine
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

A Mansour, and J H Meador-Woodruff, and D M Camp, and T E Robinson, and J Bunzow, and H Van Tol, and O Civelli, and H Akil, and S J Watson
Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems.
June 1992, Neuroscience,
A Mansour, and J H Meador-Woodruff, and D M Camp, and T E Robinson, and J Bunzow, and H Van Tol, and O Civelli, and H Akil, and S J Watson
Induction of D2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model.
May 1992, Brain research bulletin,
A Mansour, and J H Meador-Woodruff, and D M Camp, and T E Robinson, and J Bunzow, and H Van Tol, and O Civelli, and H Akil, and S J Watson
The effects of dopamine D-1 and D-2 receptor subtype agonists on nigrostriatal opioid dynorphin and enkephalin immunostaining in 6-hydroxydopamine lesioned rats.
January 1991, The Chinese journal of physiology,
A Mansour, and J H Meador-Woodruff, and D M Camp, and T E Robinson, and J Bunzow, and H Van Tol, and O Civelli, and H Akil, and S J Watson
Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen.
January 2000, Life sciences,
A Mansour, and J H Meador-Woodruff, and D M Camp, and T E Robinson, and J Bunzow, and H Van Tol, and O Civelli, and H Akil, and S J Watson
Intrastriatal administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor mRNA inhibits D2 dopamine receptor-mediated behavior and D2 dopamine receptors in normal mice and in mice lesioned with 6-hydroxydopamine.
December 1996, Neurochemistry international,
A Mansour, and J H Meador-Woodruff, and D M Camp, and T E Robinson, and J Bunzow, and H Van Tol, and O Civelli, and H Akil, and S J Watson
D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
January 1989, Synapse (New York, N.Y.),
A Mansour, and J H Meador-Woodruff, and D M Camp, and T E Robinson, and J Bunzow, and H Van Tol, and O Civelli, and H Akil, and S J Watson
D1/D2 dopamine receptor interaction in membrane abolished by 6-hydroxydopamine lesion.
January 1998, Life sciences,
A Mansour, and J H Meador-Woodruff, and D M Camp, and T E Robinson, and J Bunzow, and H Van Tol, and O Civelli, and H Akil, and S J Watson
Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
January 1992, Neuroscience,
A Mansour, and J H Meador-Woodruff, and D M Camp, and T E Robinson, and J Bunzow, and H Van Tol, and O Civelli, and H Akil, and S J Watson
Dopamine receptor supersensitivity in rat subthalamus after 6-hydroxydopamine lesions.
December 2003, The European journal of neuroscience,
A Mansour, and J H Meador-Woodruff, and D M Camp, and T E Robinson, and J Bunzow, and H Van Tol, and O Civelli, and H Akil, and S J Watson
Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult rats.
October 1991, Brain research,
Copied contents to your clipboard!